Back to top

Lilly’s LY3537031 Injection Study Reaches Completion: What Investors Should Watch

Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. The study titled “A Phase 1, 2-Part Study to Determine the Effect...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Eli Lilly and Company (LLY)